Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,999
datasets available to search
ShareScore release 0.9.0
Dataset results
1,999 results for “patient positioning”
Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02521051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients
ClinicalTrials.gov study NCT02400255. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
ClinicalTrials.gov study NCT01925183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients
ClinicalTrials.gov study NCT05289986. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
ClinicalTrials.gov study NCT04208178. IPD Sharing: YES. Countries: 7. Publications: 0.
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)
ClinicalTrials.gov study NCT01309282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
ClinicalTrials.gov study NCT01765569. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trea
ClinicalTrials.gov study NCT02658734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer
ClinicalTrials.gov study NCT02144012. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00411788. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker
ClinicalTrials.gov study NCT02926638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
ClinicalTrials.gov study NCT01928615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Measurement of Intraocular Pressure in Patients Undergoing Laminectomy in the Prone Position
ClinicalTrials.gov study NCT07067008. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04206787. IPD Sharing: YES. Countries: 1. Publications: 0.
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT02311933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
ClinicalTrials.gov study NCT02785939. IPD Sharing: Not stated. Countries: 1. Publications: 0.
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer
ClinicalTrials.gov study NCT03831711. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
ClinicalTrials.gov study NCT05849298. IPD Sharing: YES. Countries: 13. Publications: 0.
Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients
ClinicalTrials.gov study NCT00286377. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Prospective Evaluation of Cognitive Outcomes After Anesthesia on Patients in the Beach Chair Position
ClinicalTrials.gov study NCT02674334. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.